Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Diffuse cutaneous reticulohistiocytosis

D K Goette, R B Odom, J E Fitzwater

    Archives of Dermatology
    |March 1, 1982
    PubMed
    Summary
    This summary is machine-generated.

    This case study highlights a rare skin condition, multicentric reticulohistiocytosis, presenting without joint involvement. The eruption resolved spontaneously before the patient developed leukemia, suggesting a potential spectrum of disease.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Safety of itraconazole pulse therapy for onychomycosis. An update.

    Postgraduate medicine·1999
    Same author

    Topical metronidazole maintains remissions of rosacea.

    Archives of dermatology·1998
    Same author

    Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the toenail.

    Journal of the American Academy of Dermatology·1998
    Same author

    Pharmacokinetics of three doses of once-weekly fluconazole (150, 300, and 450 mg) in distal subungual onychomycosis of the toenail.

    Journal of the American Academy of Dermatology·1998
    Same author

    Mycosis fungoides with onset before 20 years of age.

    Journal of the American Academy of Dermatology·1997
    Same author

    Double-blind, randomized comparison of itraconazole capsules vs. placebo in the treatment of toenail onychomycosis.

    Cutis·1997
    Same journal

    Scoring With SCORTEN-Reply.

    Archives of dermatology·2017
    Same journal

    Comparison of Early and Late Latent Syphilis- Colorado, 1991.

    Archives of dermatology·2016
    Same journal

    Case of Rhinoscleroma.

    Archives of dermatology·2016
    Same journal

    Cutaneous Fungal Infections.

    Archives of dermatology·2016
    Same journal

    An Ulcerated Plaque in a Gay Man.

    Archives of dermatology·2016
    Same journal

    Solitary Violaceous Nodule on the Face.

    Archives of dermatology·2016
    See all related articles

    Area of Science:

    • Dermatology
    • Oncology
    • Pathology

    Background:

    • Multicentric reticulohistiocytosis (MRH) is a rare systemic histiocytic disorder typically associated with arthritis.
    • Cutaneous manifestations of MRH can vary, including papules, nodules, and plaques.

    Observation:

    • A 65-year-old man presented with a year-long, asymptomatic, diffuse cutaneous eruption of reddish-brown papules.
    • Skin lesions exhibited morphologic, light microscopic, and ultrastructural features characteristic of MRH.
    • The patient showed no clinical, laboratory, or radiographic evidence of arthritis or systemic involvement.

    Findings:

    • The cutaneous eruption of MRH resolved spontaneously after 17 months.
    • Subacute myelogenous leukemia developed in the patient several weeks after the skin lesions involuted.

    Related Experiment Videos

  • Histopathological findings were consistent with MRH, despite the absence of systemic disease.
  • Implications:

    • This case suggests that diffuse cutaneous reticulohistiocytosis without systemic involvement may represent a distinct clinical expression within the spectrum of MRH.
    • The findings support the hypothesis that isolated reticulohistiocytomas, diffuse cutaneous reticulohistiocytosis, and systemic MRH share common etiologic and pathogenetic mechanisms.
    • Further research is warranted to elucidate the relationship between cutaneous histiocytic disorders and hematologic malignancies.